Hemangioma, Capillary: Clinical Trials

7 trials for Hemangioma, Capillary, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting, 1 terminated, 1 unknown. 7 Phase 3, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Completed 4, Recruiting 1, Terminated 1, Unknown 1
Phase 24Completed 2, Recruiting 1, Terminated 1

Follow Hemangioma, Capillary: new trials by email Literature Review of Hemangioma, Capillary trials Research Report on Hemangioma, Capillary

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma
propranolol - Infantile Hemangioma
Phase 2 / Phase 3RecruitingWest China Hospital322025-01-012026-09-21
Timolol Maleate Gel for the Treatment of Infantile Hemangioma
Timolol Maleate Gel+Placebo, Timolol Maleate Gel, Placebo - Infantile Hemangioma
Phase 2 / Phase 3CompletedAuson Pharmaceuticals Inc.1682020-10-282024-11-07
Comparative Study to Evaluate the Effectiveness of Atenolol and Propranolol in the Treatment of Infantile Hemangiomas
oral propranolol, oral atenolol - Infantile Hemangioma
Phase 3UnknownPost Graduate Institute of Medical Education and Research, Chandigarh602017-03-242018-08-28
Nadolol Versus Propranolol in Children With Infantile Hemangiomas
Nadolol, Propranolol - Infantile Hemangioma
Phase 3CompletedThe Hospital for Sick Children742015-09-012020-10-28
Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma
Propranolol, Atenolol - Hemangioma
Phase 3CompletedWest China Hospital3772013-10-012022-06-16
Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy
Propranolol, Placebo - Infantile Hemangioma
Phase 2 / Phase 3CompletedPierre Fabre Dermatology5122010-01-012015-12-10
Propranolol in Capillary Hemangiomas
propranolol treatment, placebo treatment - Hemangioma, Capillary
Phase 2 / Phase 3TerminatedUniversity Hospital, Bordeaux142008-10-012026-06-01

Narrower conditions

Hemangioma (2)  ·  Ulcer (1)

Broader conditions

Neoplasms (7)  ·  Neoplasms by Histologic Type (7)  ·  Neoplasms, Vascular Tissue (7)  ·  Hemangioma (5)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Propranolol (5)  ·  Atenolol (2)  ·  Nadolol (1)

Sponsors

West China Hospital (2)  ·  Auson Pharmaceuticals Inc. (1)  ·  Pierre Fabre Dermatology (1)  ·  Post Graduate Institute of Medical Education and Research, Chandigarh (1)  ·  The Hospital for Sick Children (1)  ·  University Hospital, Bordeaux (1)

Countries

China (3)  ·  Canada (2)  ·  France (2)  ·  Australia (1)  ·  Czechia (1)  ·  Germany (1)  ·  Hungary (1)  ·  India (1)  ·  Italy (1)  ·  Lithuania (1)  ·  Mexico (1)  ·  New Zealand (1)  ·  Peru (1)  ·  Poland (1)  ·  Romania (1)

Top investigators

Christine Labreze, MD (1)  ·  Elena Pope, MD, MSc (1)  ·  Nicholas Moore, Professor (1)  ·  Yi Ji, MD, PhD (1)

Results publications

PMID 23301692, PMID 25693013, PMID 26813215, PMID 29571951, PMID 33856430, PMID 34747977

NIH funding

2008 (1)